Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
The authors concluded that overall survival was more prolonged in treatment-experienced patients with advanced renal cell carcinoma, and fewer grade 3 or 4 adverse events occurred with nivolumab than with everolimus.
Motzer et al. 2015…